457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)vinorelbine combination as first line treatment in HER2eu negative metastatic breast cancer (MBC)

F.Farhat; J.Kattan; K.Ibrahim; N.Bitar; N.Haddad; S.Tamraz; H.Hatoum; A.Shamseddine

首页> 外文期刊>European Journal of Cancer Supplements >457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)vinorelbine combination as first line treatment in HER2eu negative metastatic breast cancer (MBC)

【24h】

457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)vinorelbine combination as first line treatment in HER2eu negative metastatic breast cancer (MBC)

机译：457 HER2 / neu阴性转移性乳腺癌（MBC）一线治疗脂铂（顺铂脂质体）长春瑞滨联合治疗的II期研究的初步结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第3期|共1页
作者
F.Farhat; J.Kattan; K.Ibrahim; N.Bitar; N.Haddad; S.Tamraz; H.Hatoum; A.Shamseddine;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2eu-negative metastatic breast cancer. [J] . Farhat FS, Temraz S, Kattan J, Clinical breast cancer . 2011,第6期

机译：脂质铂（顺铂脂质体）/长春瑞滨联合治疗HER-2 /中性阴性转移性乳腺癌的II期研究。
2. Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study [J] . F.Nolè, Catania, G.Sanna, European Journal of Cancer Supplements . 2006,第2期

机译：II期研究，口服长春瑞滨联合卡培他滨的剂量确定为转移性乳腺癌（MBC）的一线化疗：II期研究的初步结果
3. 2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC) [J] . N.Tubiana-Mathieu, P.Bougnoux, D.Becquart, European Journal of Cancer Supplements . 2007,第4期

机译：2130海报更新了一项国际II期研究的分析，该研究评估了口服长春瑞滨和卡培他滨的全口服组合作为一线化疗治疗HER2阴性转移性乳腺癌（MBC）
4. Gemcitabine + Cisplatin Combination Electrochemotherapy for Triple Negative Breast Cancers: An in vitro Model Study [C] . R. Sundararajan, V. Raman, V. Masterson World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food Environmental Technologies . 2016

机译：Gemcitabine +顺铂组合电化学疗法三重阴性乳腺癌：体外模型研究
5. Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies [D] . Wang, Zixu. 2019

机译：EGCG和DAC组合治疗对治疗三重阴性乳腺癌的影响及辅助免疫检查点梗阻疗法
6. Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial [O] . Winston W. Tan, Jacob B. Allred, Muhammad Salim, -1

机译：Capecitabine的II期介入研究（N0337）与血列林和曲妥珠单抗组合的HER2阳性转移性乳腺癌的第一或二线治疗：北中央癌症治疗组试验
7. A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerA phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer [O] . Trinh, X B, Sas, L, Van Laere, Steven, 2012

机译：内分泌治疗与硼替佐米联合治疗耐内分泌转移性乳腺癌的II期研究内分泌治疗与硼替佐米联合治疗耐内分泌转移性乳腺癌的II期研究

457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)vinorelbine combination as first line treatment in HER2eu negative metastatic breast cancer (MBC)

著录项

相似文献

相关主题

期刊订阅